PS
Pallavi Sagar Salgaocar
About Pallavi Sagar Salgaocar
Data last updated:
Pallavi Sagar Salgaocar is a Whole-Time Director at Geno Pharmaceuticals Private Limited (since 2004), Director at Estilo Moderno Realty Private Limited (since 2012) and Director at Sharvani Buildcon Private Limited (since 2010), and holds 2 more current directorships. The companies operate in Pharma, Real Estate and Construction and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹349 Cr; the largest is Geno Pharmaceuticals Private Limited at ₹349 Cr (FY 2025). Earlier, Pallavi Sagar Salgaocar was a Director at Dainty Delights Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 30 Sep 2004 | 1975 | ₹349 Cr (FY 2025) | Active | |
| Director | 25 Sep 2012 | 2012 | ₹14,791 (FY 2025) | Active | |
| Director | 31 Dec 2010 | 2010 | ₹11,800 (FY 2025) | Active | |
| Director | 27 Feb 2020 | 2020 | ₹2,602 (FY 2025) | Active | |
| Director | 21 May 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Sep 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pallavi Sagar Salgaocar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilip Salgaocar Ramacrisna | 00044240 | Geno Pharmaceuticals Private Limited | Director |
| Pramod Dilip Salgaocar | 00044595 | Geno Pharmaceuticals Private Limited | Whole-Time Director |
| Sagar Dilip Salgaocar | 00044689 | Geno Pharmaceuticals Private Limited , Estilo Moderno Realty Private Limited and 3 more | Managing Director |
| Shivam Sagar Salgaocar | 10365889 | Geno Pharmaceuticals Private Limited | Director |
| Suriakiran Umacanta Sinaikunde | 06960059 | Geno Pharmaceuticals Private Limited | Director |
| Teja Mahesh Gadekar | Geno Pharmaceuticals Private Limited | Company Secretary | |
| Eknath Shankar Dhuri | 06999910 | Estilo Moderno Realty Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pallavi Sagar Salgaocar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pallavi Sagar Salgaocar
Pallavi Sagar Salgaocar currently holds 5 directorships: Geno Pharmaceuticals Private Limited (Whole-Time Director, since 30 Sep 2004, revenue ₹349 Cr (FY 2025)); Estilo Moderno Realty Private Limited (Director, since 25 Sep 2012, revenue ₹14,791 (FY 2025)); Sharvani Buildcon Private Limited (Director, since 31 Dec 2010, revenue ₹11,800 (FY 2025)); Estilo Property Management Private Limited (Director, since 27 Feb 2020, revenue ₹2,602 (FY 2025)); Estilo Moderno Ventures Private Limited (Director, since 21 May 2020).
Pallavi Sagar Salgaocar was first appointed on 30 Sep 2004 as Whole-Time Director at Geno Pharmaceuticals Private Limited. The most recent appointment on record is 21 May 2020 at Estilo Moderno Ventures Private Limited.
The 4 current companies of Pallavi Sagar Salgaocar that report revenue have a combined latest revenue of ₹349 Cr: Geno Pharmaceuticals Private Limited ₹349 Cr (FY 2025); Estilo Moderno Realty Private Limited ₹14,791 (FY 2025); Sharvani Buildcon Private Limited ₹11,800 (FY 2025); Estilo Property Management Private Limited ₹2,602 (FY 2025).
Pallavi Sagar Salgaocar held 1 earlier board appointment: Dainty Delights Private Limited (Director, from 25 Sep 2012).
The current boards of Pallavi Sagar Salgaocar's companies include Dilip Salgaocar Ramacrisna (Geno Pharmaceuticals Private Limited), Pramod Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Sagar Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Shivam Sagar Salgaocar (Geno Pharmaceuticals Private Limited), Suriakiran Umacanta Sinaikunde (Geno Pharmaceuticals Private Limited), Teja Mahesh Gadekar (Geno Pharmaceuticals Private Limited), among others.